pyrazines has been researched along with Histiocytosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aline-Fardin, A; Aucouturier, P; Bender, S; Boffa, JJ; Brahimi, S; Buob, D; Fabiani, B; Garderet, L; Mothy, M; Ronco, P; Verpont, MC | 1 |
| Bai, C; Hu, X; Liu, J; Song, X; Wang, J | 1 |
2 other study(ies) available for pyrazines and Histiocytosis
| Article | Year |
|---|---|
Pseudo-Peritoneal Carcinomatosis Presentation of a Crystal-Storing Histiocytosis With an Unmutated Monoclonal κ Light Chain.
Topics: Aged; Antineoplastic Agents; Boronic Acids; Bortezomib; Crystallization; Histiocytosis; Humans; Immunoglobulin kappa-Chains; Kidney; Lymph Nodes; Macrophages; Male; Monoclonal Gammopathy of Undetermined Significance; Peritoneal Neoplasms; Pyrazines | 2015 |
Bortezomib combined with thalidomide and dexamethasone is effective for patient with crystal-storing histiocytosis associated with monoclonal gammopathy of undermined significance.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Hormonal; Boronic Acids; Bortezomib; Dexamethasone; Female; Histiocytosis; Humans; Paraproteinemias; Pyrazines; Thalidomide | 2012 |